Tableaux »

Lineage Cell Therapeutics In shares owned by Tableaux

Quarter-by-quarter ownership of Lineage Cell Therapeutics In (LCTX) shares owned by Tableaux from 13F filings

Historical chart of Tableaux investment in Lineage Cell Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including Lineage Cell Therapeutics In held by Tableaux consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lineage Cell Therapeutics In by Tableaux

Quarter filed Position value Share count Share price at filing
2026-09-30 $28k 29k 0.96

More positions owned by Tableaux

Spdr Series Trust St Str P500etf (SPYM)
Fidelity Covington Trust Enhanced Intl (FENI)
Ea Series Trust Freedom 100 Em (FRDM)
Ishares Tr U.s. Tech Etf (IYW)
Dfa Invt Dimensions Group In U.s. High Relati (DUHP)
Apple (AAPL)
Ishares Gold Trust Micro Shs Repstg Un Tr (IAUM)
Pacer Fds Tr Us Cash Cows 100 (COWZ)
J P Morgan Exchange Traded F Core Plus Bd Etf (JCPB)
Blackrock Etf Trust Ii Isha Flex In Etf (BINC)
Dimensional Etf Trust Us Core Eqt Mkt (DFAU)
Tcw Etf Trust Flexible Income (FLXR)
Dimensional Etf Trust Intl High Profit (DIHP)
J P Morgan Exchange Traded F Us Qualty Fctr (JQUA)
American Centy Etf Tr Us Large Cap Vlu (AVLV)

View all positions for Tableaux

Top funds holding Lineage Cell Therapeutics In

Broadwood Capital
BlackRock
Vanguard Capital Management
Defender Capital
Geode Capital Management
Raffles Associates
Fifth Third Bancorp
Millennium Management
State Street Corporation
Vanguard Fiduciary Trust
Northern Trust
Renaissance Technologies
Marshall Wace
Vanguard Portfolio Management
UBS Group

View all funds holding Lineage Cell Therapeutics In